THANK YOU FOR SUBSCRIBING
Weekly Brief
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Healthcare Tech Outlook
Brendon Loiselle, Chief Business Development Officer, CDL Nuclear TechnologiesWith growing interest in advanced cardiac imaging, more physician groups and hospital systems are considering Cardiac PET. Despite its clinical value, adoption is complex and requires coordination across financial, operational, regulatory, and clinical areas. Decision-makers must carefully balance risks and opportunities.
For many providers, the question is not whether to adopt Cardiac PET, but how to implement it effectively. Capital investment, staffing, reimbursement uncertainty, facility design, licensure, and program economics all create barriers.
CDL Nuclear Technologies has built its approach around reducing those barriers to adoption. Recognized by Healthcare Tech Outlook in 2026 as one of the leading Cardiac PET and SPECT Imaging Solutions of the Year, the company has developed a model designed to help physician groups and hospital systems move into Cardiac PET with greater confidence—Cardiac PET 360.
The Challenge of Entering a Complex Modality
How do financial, operational, and regulatory challenges affect cardiac PET adoption decisions?
A Cardiac PET program requires significant investment in equipment, facilities, and workflows. Uncertainties about volume, staffing, reimbursement, and the burden of licensure or regulatory approvals can also cause hesitation.
Even hospitals and health systems, despite their scale, are not immune to these concerns. Larger organizations may have more resources, but they also tend to have more stakeholders, more internal approvals, and greater complexity.
This is where implementation support becomes critical. The need is not simply for equipment, but for a partner that can reduce friction across the entire process.
A Framework Designed to Reduce Risk
Why is implementation support considered essential when entering complex cardiac imaging modalities?
CDL Nuclear’s answer to those concerns is Cardiac PET 360, a comprehensive approach to building and growing cardiac PET programs. Rather than a single solution, it brings together a range of flexible service pathways, from mobile access to fully integrated suites, designed to meet organizations where they are in their adoption journey. As clinical demand, operational readiness, and volume evolve, Cardiac PET 360 allows programs to scale, transition, and expand with the support needed to sustain long-term success.
This framework integrates planning, facility development, staffing, regulatory navigation, reimbursement assistance, and ongoing management into a set of adaptable solutions that align with each organization’s stage of adoption. As a result, it enables the company to shield clients from risks that make Cardiac PET adoption difficult.
“With our Cardiac PET 360 model, organizations gain a partner who guides them from contract signing to the first patients in an expedited manner,” says Brendon Loiselle, chief business development officer. This approach helps organizations move forward with confidence, reducing disruption while managing risk.
Experience Built Through Refinement
Providers eager to begin scanning patients often cannot afford a prolonged rollout. The company’s model is built to reduce friction points and create a faster, more streamlined path from contract signing to go-live.
In what ways does a flexible framework help reduce risks in cardiac PET programs?
CDL Nuclear brings more than 30 years of experience supporting cardiac imaging programs nationwide, with a model refined through real-world implementation to reduce delays and accelerate time to go-live.
-
With our Cardiac PET 360 model, organizations gain a partner who guides them from contract signing to the first patients in an expedited manner.
Providers eager to begin scanning patients often cannot afford a prolonged rollout. The company’s model is built to reduce friction points and create a faster, more streamlined path from contract signing to go-live.
The Value of National Partnerships and Purchasing
Implementation expertise is only part of the equation. CDL Nuclear describes itself as one of the largest purchasers of Rubidium and PET/CT systems, which can translate into more favorable pricing, better service arrangements, and stronger supply access for clients.
In addition to pricing leverage, the company has built working relationships with key third parties across the implementation chain, including camera manufacturers, service providers, ancillary equipment vendors, and state agencies involved in radioactive materials licensure.
It also helps organizations navigate certificate-of-need requirements in applicable markets, a process that can involve population analysis, utilization projections, documentation, and public hearings. For providers unfamiliar with those hurdles, having an experienced guide can help reduce both delay and uncertainty.
Building Fixed Cardiac PET Suites on an Accelerated Timeline
For providers ready to invest in a permanent program, CDL Nuclear offers customized Cardiac PET suite buildouts designed to support a smooth transition from contract signing to scanning, depending on site-specific factors.
A fixed suite buildout requires coordination across design, infrastructure, and regulatory requirements. By relying on a repeatable implementation model and established external partnerships, the company aims to reduce delays and make permanent Cardiac PET programs more feasible for organizations that might otherwise view them as too complex or time-intensive.
CardioNavix and a Lower-Risk Path to Entry
Not every provider is ready for a full-time fixed program. For those with existing PET/CT capacity but uncertain cardiac volume, CardioNavix offers a flexible entry point within Cardiac PET 360 by delivering Rubidium as needed.
In practice, this gives providers a way to “walk before they run,” starting with lower-commitment access and expanding into more permanent solutions as demand grows. A site can begin with one day per week, expand to two or three as demand grows, and then transition into a full-time program if volume supports it.
Support That Continues After Go-Live
One of the more significant aspects of CDL Nuclear’s model is that support does not end once the first patients are scanned. The company emphasizes an ongoing partnership structure that includes physician and technologist training, access to nationally recognized experts, and continued assistance as programs mature.
Ongoing support also includes quarterly analysis of PET lab data, helping clients track programs and evaluate growth. CDL Nuclear's account managers stay connected to performance and help plan for scaling.
“Building a Cardiac PET program is achievable when the economic model supports long-term sustainability,” says Loiselle.
Preparing for the Next Phase of Advanced Imaging
While the company’s central focus is cardiac imaging, it is also looking ahead to adjacent areas of opportunity. Emerging isotope options, including Flurpiridaz F-18, are part of that conversation and ensure clients are prepared to adopt new technologies as clinical practice evolves.
Beyond cardiology, CDL Nuclear points to growing opportunities for PET imaging in urology and neurology, particularly in prostate cancer and Alzheimer’s disease amyloid imaging. In both specialties, the company sees familiar patterns: strong clinical potential, growing provider interest, and a need for operational models that simplify adoption.
Expanding Access by Making Adoption Easier
For physician groups, hospitals, and health systems evaluating how to expand advanced cardiac imaging, that promise of reduced complexity can be just as important as the technology itself. When providers feel supported across planning, implementation, reimbursement, staffing, and long-term growth, Cardiac PET follows a clear path from consideration to execution.
Advancing Cardiac PET and SPECT Imaging Access
Cardiovascular disease continues to drive enormous diagnostic demand across health systems, yet many providers still struggle to adopt advanced nuclear cardiology tools that can identify ischemia earlier and guide treatment more precisely. Cardiac PET and modern SPECT imaging have demonstrated clinical value in perfusion assessment, risk stratification and therapy planning, but the path from interest to a functioning program remains complicated for many physician groups and hospital systems. Financial exposure, staffing readiness and regulatory compliance often shape adoption decisions more than clinical enthusiasm. Imaging leaders evaluating these technologies therefore focus less on theoretical advantages and more on whether a solution can make advanced diagnostics practical within everyday clinical workflows.
Capital intensity remains one of the most persistent barriers. A full cardiac PET program typically requires a multimillion dollar imaging system, facility preparation and specialized isotopes that add significant monthly operating costs. Smaller cardiology practices or community hospitals often hesitate to commit that level of investment without clear evidence that patient volumes will support the program. Decision makers therefore prioritize models that reduce upfront exposure, allow programs to scale gradually and offer predictable reimbursement management. Diagnostic technologies that arrive with structured financial planning, billing guidance and protection against reimbursement volatility provide a clearer path for institutions attempting to modernize their cardiac imaging capabilities.
Complexity also extends beyond equipment purchases. Imaging programs demand coordination among physicians, technologists, contractors, regulators and hospital administrators before the first patient scan occurs. Facilities must navigate construction design, radiation licensing, accreditation and staff training while maintaining clinical continuity. Health systems increasingly value partners that compress this implementation timeline through standardized project management, experienced clinical training and established vendor networks. Solutions that translate specialized nuclear cardiology requirements into repeatable implementation processes allow physician groups to move from concept to patient care without prolonged disruption or uncertainty.
Another important consideration involves how widely advanced diagnostics can reach patients. Large academic centers may already operate PET scanners, yet many community sites still rely heavily on older imaging methods because new programs appear too complex or costly to launch. Models that extend PET capabilities into smaller practices or underutilized imaging suites help broaden access to higher sensitivity cardiac testing. Flexible isotope delivery, part time scanning options and shared infrastructure strategies allow health systems to evaluate demand before committing to full scale expansion while still introducing physicians to PET based diagnostics.
Healthcare executives therefore increasingly evaluate imaging partners on their ability to simplify adoption while preserving clinical rigor. Programs that combine economic flexibility, disciplined implementation and continuing physician support tend to accelerate PET adoption because they remove uncertainty from financial and clinical decision making across large provider networks.
CDL Nuclear Technologies has built its cardiac imaging programs around addressing those adoption barriers. Its Cardiac PET 360 model guides physician groups and hospitals from contract signing to first patient scans in roughly six months while coordinating facility preparation, staffing, reimbursement support and regulatory documentation.
The company also deploys CardioNavix, a mobile Rubidium program that allows sites to perform cardiac PET on a part time basis using existing scanners rather than committing immediately to a full time isotope supply. Combined with national purchasing relationships for PET systems and isotopes, this approach reduces cost exposure while giving cardiology teams a structured path to expand advanced cardiac imaging.
...Read more
Cardiac PET and SPECT Imaging Solutions Info
Q1
What Are Cardiac PET and SPECT Imaging Solutions?
Cardiac PET and SPECT Imaging Solutions refer to advanced nuclear cardiology programs that help providers assess blood flow, cardiac risk, and treatment direction through specialized imaging. The category includes not only scanners, software, radiotracers, and clinical workflows, but also the operational support needed to make these modalities practical in everyday care. For hospitals and physician groups, the value lies in pairing diagnostic capability with implementation models that reduce uncertainty, protect continuity, and support more confident program decisions.
Q2
How Does CDL Nuclear Technologies Support Cardiac PET Adoption?
CDL Nuclear Technologies supports Cardiac PET and SPECT Imaging Solutions through its Cardiac PET 360 model, which is designed to help organizations move from planning to patient scanning with fewer obstacles. Its work spans facility preparation, staffing guidance, reimbursement support, regulatory coordination, and ongoing program management. The company also offers flexible pathways, including mobile access and fixed suite buildouts, so providers can match adoption to demand rather than commit to one rigid launch model.
Q3
Why Is Implementation Planning Important in Advanced Cardiac Imaging?
Implementation planning matters because advanced cardiac imaging involves more than equipment selection. Organizations must evaluate space, workflow, isotope access, licensure, staff readiness, reimbursement, and expected volume before launching a program. Cardiac PET and SPECT Imaging Solutions are strongest when these factors are addressed together, allowing clinical teams to introduce high-value diagnostics without disrupting daily operations, delaying first scans, or taking on avoidable financial risk.
Q4
What Should Providers Consider Before Expanding Nuclear Cardiology Services?
Providers should look at clinical demand, internal approvals, site readiness, financial exposure, and long-term program sustainability. They should also assess whether a solution can scale as volume increases instead of requiring a single large commitment at the outset. Cardiac PET and SPECT Imaging Solutions that combine flexible access, training, regulatory guidance, and performance review can help organizations build a realistic path from early use to mature service delivery while keeping economics and workflow aligned.
Q5
What Makes CDL Nuclear Technologies Relevant to Cardiac PET and SPECT Imaging Solutions?
CDL Nuclear Technologies is relevant because it combines program design with practical execution. Its CardioNavix offering allows sites with existing PET/CT capacity to begin cardiac PET on a part-time basis through Rubidium delivery, then expand as demand grows. The company also draws on national purchasing relationships for PET/CT systems and Rubidium, along with experience coordinating vendors, service partners, and regulatory agencies. That makes Cardiac PET and SPECT Imaging Solutions easier to evaluate as a staged investment.
Q6
How Do These Solutions Help Improve Access to Cardiac Diagnostics?
These solutions help improve access by lowering the operational barriers that often keep advanced imaging concentrated in larger or better-resourced settings. Instead of treating adoption as a single equipment purchase, Cardiac PET and SPECT Imaging Solutions can create staged pathways that support planning, training, isotope logistics, and continued program oversight. That structure gives more organizations a clearer route to reliable cardiac imaging capacity and helps programs keep improving after the first patients are scanned.
Company
CDL Nuclear Technologies
Management
Brendon Loiselle, Chief Business Development Officer, CDL Nuclear Technologies
Description
CDL Nuclear Technologies is a provider of advanced imaging solutions for hospitals and physician groups. The company delivers a range of flexible, scalable pathways to Cardiac PET/CT through its Cardiac PET 360 approach, enabling organizations to adopt, expand, and sustain programs tailored to their specific needs and growth trajectories. Through this approach, CDL Nuclear helps healthcare organizations implement, expand, and enhance access to advanced diagnostics.
